• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病细胞中端粒长度与端粒酶活性及表达之间缺乏相关性。

Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.

作者信息

Januszkiewicz Danuta, Wysoki Jacek, Lewandowski Krzysztof, Pernak Monika, Nowicka Karina, Rembowska Jolanta, Nowak Jerzy

机构信息

Institute of Human Genetics PAN, Polish Academy of Sciences, Strzeszynska 32, 60-479 Poznan, Poland.

出版信息

Int J Mol Med. 2003 Dec;12(6):935-8.

PMID:14612969
Abstract

The expression of three components of telomerase complex (hTR, hTERT, TP1) along with telomerase activity and telomere length in leukemic cells was investigated. Cells were isolated from peripheral blood and/or bone marrow of children with acute lymphoblastic (ALL) and non-lymphoblastic (ANLL) leukemia. Expression of three components of telomerase as well as telomerase activity was found in all leukemic cells. Chemiluminescent detection of terminal restriction fragments (TRF) from DNA isolated from ALL cells showed variable patterns expressing considerable heterogeneity of telomere length. The ALL cells appeared to have both long and short telomere lengths, in contrast to normal peripheral lymphocytes, which produced limited pattern of TRF. The ANLL cells produced predominantly short telomere pattern despite high telomerase activity and expression. It can be concluded that high telomerase activity and expression in leukemic cells is not always correlated with long telomeres (TRF pattern).

摘要

研究了白血病细胞中端粒酶复合物的三个组分(hTR、hTERT、TP1)的表达以及端粒酶活性和端粒长度。细胞取自急性淋巴细胞白血病(ALL)和非淋巴细胞白血病(ANLL)患儿的外周血和/或骨髓。在所有白血病细胞中均发现了端粒酶三个组分的表达以及端粒酶活性。对从ALL细胞中分离的DNA进行末端限制片段(TRF)的化学发光检测,结果显示出不同的模式,表明端粒长度存在显著异质性。与正常外周淋巴细胞产生有限的TRF模式不同,ALL细胞似乎同时具有长端粒和短端粒长度。尽管ANLL细胞具有较高的端粒酶活性和表达,但主要产生短端粒模式。可以得出结论,白血病细胞中的高端粒酶活性和表达并不总是与长端粒(TRF模式)相关。

相似文献

1
Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.白血病细胞中端粒长度与端粒酶活性及表达之间缺乏相关性。
Int J Mol Med. 2003 Dec;12(6):935-8.
2
Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.端粒酶具有高表达和高活性的白血病细胞中hTERT和hTERC基因的扩增。
Oncol Rep. 2006 Aug;16(2):301-5.
3
Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.人食管癌细胞中的端粒长度、端粒酶活性及端粒酶RNA表达:与细胞增殖、分化及对抗癌药物的化疗敏感性的相关性
Anticancer Res. 1998 May-Jun;18(3A):1465-72.
4
Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts.端粒酶活性水平而非hTERT mRNA和hTR水平调节端粒酶重构的原代成纤维细胞中的端粒长度。
Exp Cell Res. 2004 Jul 15;297(2):434-43. doi: 10.1016/j.yexcr.2004.03.028.
5
Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.简明综述:正常及白血病造血干细胞中的端粒生物学
Stem Cells. 2007 Aug;25(8):1853-61. doi: 10.1634/stemcells.2007-0057. Epub 2007 May 17.
6
Telomeres and telomerase in normal and malignant haematopoietic cells.正常和恶性造血细胞中的端粒与端粒酶
Eur J Cancer. 1997 Apr;33(5):774-80. doi: 10.1016/S0959-8049(97)00059-2.
7
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.端粒替代延长细胞中端粒酶基因表达的缺失与hTR和hTERT基因启动子的染色质重塑相关。
Cancer Res. 2005 Sep 1;65(17):7585-90. doi: 10.1158/0008-5472.CAN-05-1715.
8
Telomeres and telomerase in leukaemia and lymphoma.白血病和淋巴瘤中的端粒与端粒酶
Transfus Apher Sci. 2007 Aug;37(1):43-7. doi: 10.1016/j.transci.2007.04.006. Epub 2007 Sep 4.
9
Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.通过表达显性负性hTERT突变体抑制端粒酶后,人白血病细胞系中的端粒功能障碍和端粒酶重新激活。
Oncogene. 2002 Nov 28;21(54):8262-71. doi: 10.1038/sj.onc.1206054.
10
Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.在缺乏与端粒延长相关的早幼粒细胞白血病小体的替代延长的情况下,不依赖端粒酶的端粒长度维持。
Cancer Res. 2005 Apr 1;65(7):2722-9. doi: 10.1158/0008-5472.CAN-04-2881.

引用本文的文献

1
Targeting Telomere Biology in Acute Lymphoblastic Leukemia.靶向急性淋巴细胞白血病中的端粒生物学。
Int J Mol Sci. 2021 Jun 22;22(13):6653. doi: 10.3390/ijms22136653.
2
Telomerase Regulation: A Role for Epigenetics.端粒酶调控:表观遗传学的作用
Cancers (Basel). 2021 Mar 10;13(6):1213. doi: 10.3390/cancers13061213.
3
The regulation of telomerase in oncogenesis.端粒酶在肿瘤发生中的调控。
Acta Naturae. 2009 Apr;1(1):51-67.
4
The association between telomerase activity and expression of its RNA component (hTR) in breast cancer patients: the importance of DNase treatment.乳腺癌患者端粒酶活性与其RNA组分(hTR)表达之间的关联:DNA酶处理的重要性。
J Carcinog. 2006 Jun 2;5:17. doi: 10.1186/1477-3163-5-17.